Healio

FDA approves updated label with new dosing guidance for inhaled insulin

The FDA has approved a label update for an inhaled insulin indicated for adults with type 1 or type 2 diabetes, according to ...
MedPage Today on MSN

FDA Halts Two Gene Therapy Trials After Child Develops Brain Tumor

Studies of Hunter and Hurler syndromes on hold ...

As billionaires chase immortality, this startup cofounded by a Harvard genetics professor gets FDA approval for the first partial de-aging human trial

Life Biosciences will test its gene therapy designed to partially reset a cell’s age and potentially reverse vision loss in ...
Targeted Oncology

FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC

Ivonescimab's BLA acceptance is a milestone for PD-1/VEGF bispecific antibodies in the U.S., potentially transforming ...
National Law Review

Digital Health Policy- FDA Relaxes Restrictions over Wearables and AI Decision Making Tools in Two New 2026 Guidances

On January 6, 2026, the U.S. Food & Drug Administration (FDA) updated two guidance documents, General Wellness: Policy for ...
MedPage Today on MSN

FDA OKs More Eye Drops That Can Replace Reading Glasses

Once-daily carbachol/brimonidine tartrate significantly improves aging-related vision loss ...
Becker's Hospital Review

FDA puts hold on gene therapy trials after brain tumor

After finding an intraventricular tumor in one clinical trial participant, the FDA placed a clinical hold on an experimental ...

FDA Decision on Eli Lilly's Weight Loss Pill Delayed to Q2. Is This Bad News for the Stock?

The target action date for orforglipron is now April 10.
Parade on MSN

FDA Recall: Check for Contaminated Foods and Products from Gold Star Distribution

A massive multi-category product recall has been issued after a pest infestation discovery.
Becker's Hospital Review

FDA fast-tracks ADHD drug for priority review

The FDA has accepted Otsuka’s New Drug Application for centanafadine, a first-in-class norepinephrine, dopamine and serotonin reuptake inhibitor (NDSRI) for the treatment of attention-deficit ...